Literature DB >> 15259510

Immune escape mechanism: defective resting and stimulated leukocyte-endothelium interaction in hepatocellular carcinoma of the rat.

Sasa-Marcel Maksan1, Patrick Morad Araib, Eduard Ryschich, Martha Maria Gebhard, Jan Schmidt.   

Abstract

Hepatocellular carcinoma represents an increasing therapeutic challenge due to its high incidence and early metastasis. Numerous studies have demonstrated the influence of the vascular system on tumor growth and development. In addition, the role of leukocyte-endothelium interaction in tumor vessels is of particular significance with regard to immunological tumor therapy. In this study we used an experimental in vivo animal model that allows a quantitative analysis on vessel morphology, microcirculation, and leukocyte-endothelium interaction. The vessel architecture in tumor tissue was found to be extremely heterogeneous, with a consecutively variable blood flow velocity. Following superfusion with chemotactic factors (fMLP, LB4), the leukocyte-endothelium interaction in tumor tissue with respect to leukocyte sticking was significantly reduced in comparison to healthy liver tissue. In conclusion, one of the main mechanisms for the reduced leukocyte-endothelium interaction in tumor tissue seems to be a decreased expression of adhesion molecules such as ICAM-1, indicating an effective immune escape mechanism for this tumor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259510     DOI: 10.1023/b:ddas.0000030100.05979.b7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  Nonsurgical treatment of hepatocellular carcinoma.

Authors:  A Aguayo; Y Z Patt
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

2.  Vascular endothelium-leukocyte interaction; sticking shear force in venules.

Authors:  G W Schmid-Schoenbein; Y C Fung; B W Zweifach
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

Review 3.  Lymphocyte interactions with endothelial cells.

Authors:  Y Shimizu; W Newman; Y Tanaka; S Shaw
Journal:  Immunol Today       Date:  1992-03

Review 4.  Hyperthermia and microcirculatory effects of heat in animal tumors.

Authors:  B Endrich
Journal:  Recent Results Cancer Res       Date:  1988

5.  Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.

Authors:  J Chia-Hsien Cheng; V P Chuang; S H Cheng; Y M Lin; T I Cheng; P S Yang; J J Jian; D L You; C F Horng; A T Huang
Journal:  Int J Cancer       Date:  2001-08-20       Impact factor: 7.396

6.  Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer.

Authors:  J Schmidt; E Ryschich; S M Maksan; J Werner; M M Gebhard; C Herfarth; E Klar
Journal:  Int J Pancreatol       Date:  1999-12

Review 7.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Transformation of the microvascular system during multistage tumorigenesis.

Authors:  Eduard Ryschich; Jan Schmidt; Günter J Hämmerling; Ernst Klar; Ruth Ganss
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

9.  Significance of blood vessel leakiness in cancer.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

10.  Effects of IL-8, Gro-alpha, and LTB(4) on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils.

Authors:  S M Seo; L V McIntire; C W Smith
Journal:  Am J Physiol Cell Physiol       Date:  2001-11       Impact factor: 4.249

View more
  4 in total

1.  Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy.

Authors:  Roman A Blaheta; Maciej Powerski; Lukasz Hudak; Eva Juengel; Dietger Jonas; Andreas von Knethen; Hans Willhelm Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

Review 2.  The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.

Authors:  Shona A Hendry; Rae H Farnsworth; Benjamin Solomon; Marc G Achen; Steven A Stacker; Stephen B Fox
Journal:  Front Immunol       Date:  2016-12-20       Impact factor: 7.561

3.  Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.

Authors:  Jian-Lin Chen; Xiang-Ming Lao; Xiao-Jun Lin; Li Xu; Bo-Kang Cui; Jun Wang; Guo-He Lin; Ze-Yu Shuang; Yi-Ze Mao; Xin Huang; Jing-Ping Yun; Jie-Tian Jin; Sheng-Ping Li
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

4.  Predictive Value of High ICAM-1 Level for Poor Treatment Response to Low-Dose Decitabine in Adult Corticosteroid Resistant ITP Patients.

Authors:  Chaoyang Li; Lizhen Li; Meng Sun; Jianzhi Sun; Linlin Shao; Miao Xu; Yu Hou; Jun Peng; Lin Wang; Ming Hou
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.